Melinta Therapeutics Inc said on Friday it had filed for bankruptcy protection, becoming the latest casualty of a persistent cash burn in the antibiotic industry.
The drugmaker, which has four antibiotics on the market, warned that it was running out of cash last month.
Copyright © 2021,